Nifty
:
25960.55
Sensex
:
85102.69
-225.90 (-0.86%)
-609.68 (-0.71%)
Nifty
Sensex
:
:
25960.55
85102.69
-225.90 (-0.86%)
-609.68 (-0.71%)

Bharat Parenterals Ltd.

Pharmaceuticals & Drugs

Rating :
44/99

BSE: 541096 | NSE: Not Listed

NSE BSE
1094.90
05-Dec-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1155
  •  1160
  •  1080.2
  •  1162.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  988
  •  1090811
  •  1160
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 754.60
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 870.42
  • 0.09%
  • 2.28

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.19%
  • 8.23%
  • 19.27%
  • FII
  • DII
  • Others
  • 0.11%
  • 0.00%
  • 5.20%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.62
  • 10.71
  • 16.02

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -12.26
  • -36.05
  • -32.99

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.16
  • 5.53
  • 2.81

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 10.46
  • 11.85

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 2.02
  • 2.46

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 22.97
  • 34.16

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Net Sales
64.62
71.63
-9.79%
116.00
92.51
25.39%
103.98
67.82
53.32%
72.26
59.82
20.80%
Expenses
63.79
79.28
-19.54%
102.22
88.02
16.13%
101.74
66.82
52.26%
68.62
53.21
28.96%
EBITDA
0.83
-7.65
-
13.78
4.49
206.90%
2.24
1.00
124.00%
3.64
6.61
-44.93%
EBIDTM
1.28%
-10.68%
11.88%
4.85%
2.15%
1.47%
5.04%
11.05%
Other Income
3.53
4.20
-15.95%
1.06
2.54
-58.27%
1.92
2.64
-27.27%
2.95
1.26
134.13%
Interest
3.11
2.91
6.87%
3.69
2.77
33.21%
3.94
1.13
248.67%
3.33
0.58
474.14%
Depreciation
8.56
9.01
-4.99%
8.60
9.03
-4.76%
8.52
3.87
120.16%
8.76
1.82
381.32%
PBT
-7.31
-15.37
-
2.55
-4.77
-
-8.30
-1.36
-
-5.50
5.47
-
Tax
1.29
2.15
-40.00%
3.42
4.07
-15.97%
1.14
1.20
-5.00%
2.37
1.83
29.51%
PAT
-8.60
-17.52
-
-0.87
-8.84
-
-9.44
-2.56
-
-7.87
3.64
-
PATM
-13.31%
-24.46%
-0.75%
-9.56%
-9.08%
-3.77%
-10.89%
6.08%
EPS
-10.49
-11.51
-
11.94
1.96
509.18%
-6.87
-0.52
-
-2.41
6.55
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
356.86
340.38
261.22
217.98
212.01
204.64
228.18
219.54
136.58
111.44
124.11
Net Sales Growth
22.30%
30.30%
19.84%
2.82%
3.60%
-10.32%
3.94%
60.74%
22.56%
-10.21%
 
Cost Of Goods Sold
184.98
185.48
158.38
137.48
136.07
134.27
148.91
140.48
88.18
79.07
83.01
Gross Profit
171.88
154.91
102.83
80.50
75.95
70.38
79.26
79.06
48.39
32.37
41.10
GP Margin
48.16%
45.51%
39.37%
36.93%
35.82%
34.39%
34.74%
36.01%
35.43%
29.05%
33.12%
Total Expenditure
336.37
337.68
234.18
197.99
184.10
179.40
200.53
190.69
124.44
104.98
114.12
Power & Fuel Cost
-
15.24
4.69
3.75
3.21
3.10
3.19
2.70
2.62
1.79
2.06
% Of Sales
-
4.48%
1.80%
1.72%
1.51%
1.51%
1.40%
1.23%
1.92%
1.61%
1.66%
Employee Cost
-
49.66
22.79
18.00
15.37
14.75
15.58
15.37
12.94
11.37
9.10
% Of Sales
-
14.59%
8.72%
8.26%
7.25%
7.21%
6.83%
7.00%
9.47%
10.20%
7.33%
Manufacturing Exp.
-
39.24
14.95
11.16
8.43
7.35
8.60
9.12
5.01
4.07
3.78
% Of Sales
-
11.53%
5.72%
5.12%
3.98%
3.59%
3.77%
4.15%
3.67%
3.65%
3.05%
General & Admin Exp.
-
10.78
8.02
6.21
3.09
2.53
2.88
3.47
1.91
1.46
4.54
% Of Sales
-
3.17%
3.07%
2.85%
1.46%
1.24%
1.26%
1.58%
1.40%
1.31%
3.66%
Selling & Distn. Exp.
-
26.96
17.76
16.34
7.72
7.30
12.04
13.62
9.50
4.47
10.22
% Of Sales
-
7.92%
6.80%
7.50%
3.64%
3.57%
5.28%
6.20%
6.96%
4.01%
8.23%
Miscellaneous Exp.
-
10.32
7.59
5.06
10.21
10.10
9.34
5.93
4.27
2.74
10.22
% Of Sales
-
3.03%
2.91%
2.32%
4.82%
4.94%
4.09%
2.70%
3.13%
2.46%
1.14%
EBITDA
20.49
2.70
27.04
19.99
27.91
25.24
27.65
28.85
12.14
6.46
9.99
EBITDA Margin
5.74%
0.79%
10.35%
9.17%
13.16%
12.33%
12.12%
13.14%
8.89%
5.80%
8.05%
Other Income
9.46
11.62
4.72
12.04
7.93
8.68
11.90
12.74
7.17
7.71
5.05
Interest
14.07
12.95
4.02
2.60
1.31
0.77
0.86
0.87
0.94
0.91
1.49
Depreciation
34.44
35.32
9.02
5.88
6.66
6.03
5.88
6.13
5.57
5.79
4.20
PBT
-18.56
-33.95
18.72
23.55
27.88
27.12
32.80
34.59
12.79
7.48
9.35
Tax
8.22
9.72
8.21
7.83
7.06
6.81
8.65
13.35
3.68
0.59
2.89
Tax Rate
-44.29%
-28.63%
43.86%
33.25%
25.32%
25.11%
26.37%
38.59%
28.77%
7.89%
30.91%
PAT
-26.78
-12.63
14.51
16.39
21.05
20.39
24.14
21.25
9.12
6.89
6.45
PAT before Minority Interest
-5.39
-43.68
10.51
15.71
20.81
20.32
24.14
21.25
9.12
6.89
6.45
Minority Interest
21.39
31.05
4.00
0.68
0.24
0.07
0.00
0.00
0.00
0.00
0.00
PAT Margin
-7.50%
-3.71%
5.55%
7.52%
9.93%
9.96%
10.58%
9.68%
6.68%
6.18%
5.20%
PAT Growth
0.00%
-
-11.47%
-22.14%
3.24%
-15.53%
13.60%
133.00%
32.37%
6.82%
 
EPS
-38.81
-18.30
21.03
23.75
30.51
29.55
34.99
30.80
13.22
9.99
9.35

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
330.67
197.27
182.80
165.83
143.87
118.19
94.01
72.85
63.68
56.69
Share Capital
6.89
5.82
5.77
5.77
5.73
5.73
5.73
5.73
5.73
5.73
Total Reserves
323.78
191.45
176.49
160.05
137.71
112.46
88.28
67.12
57.95
50.96
Non-Current Liabilities
89.40
75.93
12.65
14.38
11.21
3.42
4.42
0.22
3.29
7.39
Secured Loans
70.99
70.66
10.92
9.75
8.59
0.71
0.97
2.34
3.67
6.57
Unsecured Loans
4.88
2.50
0.00
2.74
0.00
0.00
0.00
0.00
0.34
0.33
Long Term Provisions
4.61
2.10
1.33
0.94
0.64
0.51
0.09
0.08
0.00
0.00
Current Liabilities
229.14
189.83
119.80
41.53
43.63
65.88
60.51
56.88
42.79
56.18
Trade Payables
74.16
59.48
51.34
23.76
26.17
42.61
31.91
26.56
36.37
38.84
Other Current Liabilities
42.65
47.71
30.83
13.00
15.42
22.60
25.93
22.22
6.22
0.37
Short Term Borrowings
99.89
80.85
36.02
2.78
1.19
0.00
1.95
4.98
0.00
12.53
Short Term Provisions
12.44
1.80
1.60
1.99
0.84
0.67
0.71
3.13
0.21
4.44
Total Liabilities
657.54
503.94
350.35
226.06
198.66
187.49
158.94
129.95
109.76
120.26
Net Block
251.11
209.70
41.19
39.75
43.36
31.75
33.98
33.71
31.16
34.69
Gross Block
322.13
255.80
80.07
72.98
71.05
53.58
50.12
44.11
35.99
62.47
Accumulated Depreciation
71.02
46.10
38.88
33.22
27.69
21.83
16.14
10.40
4.83
27.78
Non Current Assets
292.18
241.92
166.06
82.32
50.63
55.88
40.91
39.12
45.78
48.64
Capital Work in Progress
31.26
24.94
99.01
25.65
0.44
12.16
1.06
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
1.31
1.36
0.00
0.55
0.50
Long Term Loans & Adv.
8.99
6.39
22.33
13.49
2.77
7.93
1.95
2.85
9.71
9.30
Other Non Current Assets
0.00
0.00
2.54
2.34
2.86
2.73
2.56
2.57
4.35
4.15
Current Assets
365.35
262.00
184.28
143.74
148.02
131.62
118.02
90.83
63.98
71.62
Current Investments
4.98
0.00
0.00
11.48
42.79
0.01
1.47
0.52
0.00
0.00
Inventories
71.95
61.47
37.84
20.76
22.43
28.82
22.52
14.43
15.27
14.12
Sundry Debtors
171.74
141.42
112.41
73.40
67.83
79.35
63.87
58.65
43.60
44.06
Cash & Bank
57.59
14.52
9.98
4.68
2.43
10.40
12.13
4.13
1.58
12.74
Other Current Assets
59.09
1.09
0.74
1.70
12.54
13.04
18.03
13.10
3.53
0.69
Short Term Loans & Adv.
56.34
43.50
23.31
31.71
12.09
12.59
17.52
12.57
0.20
0.12
Net Current Assets
136.21
72.18
64.49
102.20
104.40
65.74
57.51
33.94
21.20
15.44
Total Assets
657.53
503.92
350.34
226.06
198.65
187.50
158.93
129.95
109.76
120.26

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
-27.25
-4.71
21.66
-1.07
24.45
14.45
20.43
6.34
-2.11
0.00
PBT
-33.95
18.72
23.55
27.88
27.12
32.80
34.59
12.79
7.48
0.00
Adjustment
40.49
15.33
8.81
4.85
10.37
6.23
6.63
6.27
5.88
0.00
Changes in Working Capital
-23.19
-29.29
-1.90
-28.13
-6.37
-14.53
-10.36
-10.17
-13.88
0.00
Cash after chg. in Working capital
-16.66
4.76
30.46
4.60
31.12
24.50
30.87
8.89
-0.52
0.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-10.60
-9.46
-8.79
-5.67
-6.68
-10.04
-10.44
-2.56
-1.59
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-137.38
-104.78
-77.82
-6.63
-43.37
-12.60
-9.35
-8.07
-1.53
0.00
Net Fixed Assets
-8.17
-7.78
-0.52
-2.55
-5.31
-14.56
-7.07
-8.12
26.48
Net Investments
-119.19
-10.21
-22.10
25.52
-40.25
1.51
-2.31
0.03
-0.30
Others
-10.02
-86.79
-55.20
-29.60
2.19
0.45
0.03
0.02
-27.71
Cash from Financing Activity
156.37
110.43
60.60
9.42
10.50
-2.82
-3.89
4.04
-7.52
0.00
Net Cash Inflow / Outflow
-8.27
0.94
4.44
1.72
-8.43
-0.96
7.18
2.30
-11.16
0.00
Opening Cash & Equivalents
8.71
7.84
3.40
1.68
10.10
11.07
3.88
1.58
12.74
0.00
Closing Cash & Equivalent
0.44
8.78
7.84
3.40
1.68
10.10
11.07
3.88
1.58
0.00

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
479.79
338.96
315.63
287.16
250.34
206.27
164.07
127.14
111.14
98.95
ROA
-7.52%
2.46%
5.45%
9.80%
10.52%
13.94%
14.71%
7.61%
5.99%
5.37%
ROE
-16.55%
5.54%
9.03%
13.46%
15.53%
22.76%
25.47%
13.35%
11.45%
11.38%
ROCE
-4.85%
7.74%
12.57%
17.18%
20.24%
30.83%
39.30%
18.10%
11.47%
14.23%
Fixed Asset Turnover
1.18
1.56
2.85
3.35
3.80
4.40
4.66
3.46
2.41
2.10
Receivable days
167.45
176.78
155.57
106.98
113.54
114.55
101.85
134.69
134.78
122.67
Inventory Days
71.34
69.16
49.06
32.72
39.53
41.06
30.72
39.13
45.19
39.31
Payable days
131.49
127.69
99.70
66.97
93.48
91.33
56.53
92.40
126.93
125.22
Cash Conversion Cycle
107.30
118.25
104.93
72.73
59.59
64.28
76.03
81.42
53.04
36.75
Total Debt/Equity
0.55
0.80
0.27
0.11
0.09
0.01
0.05
0.12
0.10
0.34
Interest Cover
-1.62
5.66
10.07
22.35
36.44
38.93
40.77
14.60
9.26
7.29

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • FAMHP concludes EU GMP inspection at facility of Bharat Parenterals’ arm
    28th Nov 2025, 15:30 PM

    The inspection was carried out at the Innoxel Lifesciences’ manufacturing facility from November 24, 2025 to November 28, 2025

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.